| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |